Back to Search Start Over

Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.

Authors :
Wever-Pinzon J
Selzman CH
Stoddard G
Wever-Pinzon O
Catino A
Kfoury AG
Diakos NA
Reid BB
McKellar S
Bonios M
Koliopoulou A
Budge D
Kelkhoff A
Stehlik J
Fang JC
Drakos SG
Source :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2016 Oct 18; Vol. 68 (16), pp. 1741-1752.
Publication Year :
2016

Abstract

Background: Small-scale studies focused mainly on nonischemic cardiomyopathy (NICM) have shown that a subset of left ventricular assist device (LVAD) patients can achieve significant improvement of their native heart function, but the impact of ischemic cardiomyopathy (ICM) has not been specifically investigated. Many patients with acute myocardial infarction are discharged from their index hospitalization without heart failure (HF), only to return much later with overt HF syndrome, mainly caused by chronic remodeling of the noninfarcted region of the myocardium.<br />Objectives: This study sought to prospectively investigate the effect of ICM HF etiology on LVAD-associated improvement of cardiac structure and function using NICM as control.<br />Methods: Consecutive patients (n = 154) with documented chronic and dilated cardiomyopathy (ICM, n = 61; NICM, n = 93) requiring durable support with continuous-flow LVAD were prospectively evaluated with serial echocardiograms and right heart catheterizations.<br />Results: In patients supported with LVAD for at least 6 months, we found that 5% of subjects with ICM and 21% of subjects with NICM achieved left ventricular ejection fraction ≥40% (p = 0.034). LV end-diastolic and end-systolic volumes and diastolic function were significantly and similarly improved in patients with ICM and NICM.<br />Conclusions: LVAD-associated unloading for 6 months resulted in a substantial improvement in myocardial structure, and systolic and diastolic function in 1 in 20 ICM and 1 in 5 NICM patients. These specific incidence and timeline findings may provide guidance in clinical practice and research design for sequencing and prioritizing advanced HF and heart transplantation therapeutic options in patients with ICM and NICM.<br /> (Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1558-3597
Volume :
68
Issue :
16
Database :
MEDLINE
Journal :
Journal of the American College of Cardiology
Publication Type :
Academic Journal
Accession number :
27737740
Full Text :
https://doi.org/10.1016/j.jacc.2016.07.756